SINTX Technologies acquires Technology Assessment and Transfer Inc. – Today's Medical Developments
The acquisition broadens SINTX’s opportunities in aerospace, defense, and biomedical markets.
SINTX Technologies Inc., an original equipment manufacturer of advanced ceramics, has acquired Technology Assessment and Transfer Inc. (TA&T), increasing SINTX’s capabilities in the aerospace, defense, and biomedical markets.
TA&T is an advanced ceramics business specializing in developing and commercializing materials for defense, biomedical, and industrial applications. The company’s technologies and products include 3D printing of ceramic medical devices and heat exchangers, chemical vapor infiltration and deposition of complex fiber-reinforced ceramic-matrix composites, and hot pressing of transparent armor and other technical ceramics.
Ceramic heater bodies developed, designed, and manufactured by TA&T are part of the sample analysis on Mars (SAM) instrument suite on board the Curiosity Rover. These oven heater bodies were manufactured by TA&T using ceramic stereolithography, a form of 3D printing and additive manufacturing, and can withstand temperatures of more than the 1,500°F required to heat soil samples on Mars in hopes of detecting life.
Discover the limits and factors of robot accuracy.
About the presentation
Many robotic applications require high positional and path accuracy. These include machining, non-destructive testing, and any application that relies on off-line programming. Robots have come a long way in static and dynamic performance. However, failing to understand robot accuracy and the factors that affect it can lead to undesirable outcomes. Many users have high robot accuracy expectations. Some confuse robot repeatability with robot accuracy. Yet, others do not consider other factors that affect the overall accuracy of the system, such as end-of-arm tooling, fixtures, duty cycle, etc. This presentation provides key insights into robot accuracy, its limits, and the various factors that affect it. Recommendations are made for evaluating the use of robots in applications that require a high level of accuracy and steps to take to ensure the robot’s optimal performance. This talk aims to educate attendees about robot accuracy, factors that affect it, and ways to improve it. This allows better assessment of applications and analysis of whether a robot can replace an expensive machine, such as a CNC, in machining applications or custom-built non-destructive testing machines.
Meet your presenter
Houssaine Waled is a senior engineer at KUKA Robotics Corp. He has more than 20 years of experience in the fields of robotics and motion control. His main area of expertise is machine performance, including static and dynamic accuracy. He developed software tools to calibrate KUKA robots, both in factory settings and in the field, and cells with multiple devices (robots, tables, etc). Lately, he’s also been involved in Mobile Robots.
About the company
KUKA is a global automation company and supplier of intelligent automation solutions. KUKA offers its customers everything from a single source: from robots and cells to fully automated systems and their networking in markets such as automotive, electronics, general industry, consumer goods, e-commerce/retail, and healthcare. The KUKA Group is headquartered in Augsburg, Germany.
The patented polymeric fiber is a breakthrough in the world of miniaturizing visualization.
Zsquare, a developer of single-use endoscopes, announced it received U.S. Food and Drug Administration 510K clearance to market its first product, the Zsquare ENT-Flex Rhinolaryngoscope. Its pilot launch in U.S. hospitals and physician practice offices is scheduled for Q4 2022.
The product is indicated for use in diagnostic ENT procedures by way of the nose and throat and is a scalable platform capable of transmitting high-resolution images in flexible, single-use endoscopes. The single-use endoscope uses a hybrid design in which its all-optical disposable shell fully covers a reusable imaging core. The enhanced design provides health professionals with high resolution imaging in single-use endoscopy through its small diameter endoscope shaft. This engineering has several benefits, including improved patient comfort and enhanced diagnostic quality.
The company’s patented polymeric imaging fiber’s flexible ultra-thin properties enable smaller endoscopes that can access formerly unreachable anatomical sites without compromising image quality. The hybrid endoscope design enables cross-industry scalability by allowing the same imaging core to be used with different indication-specific disposable shells made for ENT, urology, bronchoscopy, GI, and gynecology.
How to use location data for industrial process automation.
About the presentation
While industrial companies have digitized a significant portion of their machine parks, many are losing out on a valuable pool of information – location data of moving assets along the supply chain. Location-based process automation (LPA) software provides a comprehensive digital twin of moving things that grants manufacturers unprecedented information and visibility of the location and status of assets and processes. This talk highlights how to leverage location data from sources such as BLE, UWB, GPS, and more, to realize unlimited and scalable process automation opportunities via LPA; use cases such as search and find, material flow automation, container management, automated tool control, and more can be easily set up directly on the OT level via no-code/low-code events and triggers.
Meet your presenter
Mehdi Bentanfous is the CEO of KINEXON Inc. Before joining KINEXON, he held senior positions in consulting (BCG), private equity (Waterland Private Equity), and senior management. He is responsible for global business development as well as sales and marketing of the industrial division. Bentanfous studied economics and engineering at the Karlsruhe Institute of Technology (KIT).
About the company
KINEXON provides state of the art sensor networks and edge computing solutions to manufacturing, logistics, sports, and media organizations. In addition, KINEXON developed SafeZone, the world’s most trusted digital solution for distance warning and exposure management to protect against COVID-19. KINEXON leverages location technologies to localize and connect objects, people, and processes, allowing them to interact in the most intelligent and efficient way possible.
Demand continues due to Centers for Medicare and Medicaid Services policy guidance.
Applied UV Inc. is a pathogen elimination technology company that applies the power of narrow-range ultraviolet light (UVC) for surface areas and catalytic bioconversion technology for air purification to destroy pathogens. The company announced MedLine, its exclusive North American scientific air management healthcare distribution partner, placed a large multi-unit follow-on order for its patented S200 mobile air purification system.
Since 2015, Scientific Air three-stage, advanced UVC carbon and HEPA filtration systems have been improving indoor air quality 24/7 in high-traffic, occupied spaces at healthcare facilities throughout the United States.
The follow-on order for mobile S200 air purification is in further support of the Centers for Medicare and Medicaid Services (CMS) policy announced earlier in the year to ease visitation in long-term care facilities. Under the CMS policy guidance, it provides funding available for long-term care providers looking to make air quality upgrades to their facilities to reduce the spread of COVID-19.
Additionally, the air purification sales channel is the strongest in the company’s history due to increased awareness around improving indoor air quality, the impact of the marketing campaign launched earlier in the quarter, coupled with expanded domestic distribution.
“The CMS Policy guidance acknowledges the critical role that pathogen elimination solutions can play in protecting both the frontline Heroes in Long-term Care and the elderly patients in their care in the fight against the spread of COVID-19 and other airborne pathogens,” stated John F. Andrews, Applied UV’s CEO and director. “This initiative CMS has unleashed, ensures that cost is not a barrier for long-term care providers wishing to ease visitation restrictions that have been in place, but also offers longer term solutions to protect its patients, staff, and visitors. It has been well documented the unimaginable emotional toll placed on families who have been physically separated by strict facility visitation restrictions throughout the course of this 3-year pandemic.”